Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

LSI announces publication of Emerging Medtech Companies report

Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.

30 Apr 2011

Gene therapy approach using CD59 shows promise against AMD: Study

A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration, according to a new in vivo study by researchers at Tufts University School of Medicine.

30 Apr 2011

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Age-related macular degeneration, a disease that damages the retina and can destroy central vision, affects approximately 1.6 million Americans. For the past five years, there has been active debate over treatment options for AMD patients because ophthalmologists have not had accurate data regarding the true efficacy of the most commonly used medication.

29 Apr 2011

Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A.

28 Apr 2011

Too much TV raises risk of narrow eye blood vessels and heart disease in kids

A new study has shown that children who spend more time in front of television and computer screens and less in outdoor physical activity have narrower blood vessels in their eyes. In adults, constricted blood vessels in the eyes have been linked to an increased risk of cardiovascular disease.

26 Apr 2011

Humana declares quarterly cash dividend, anticipates first quarter diluted EPS of $1.86

Humana Inc. announced today that it has realigned its business segments to more closely reflect the company's evolving business model. Effective immediately, the company will be managing and reporting its operating results using the following segments: Retail, Employer Group, and Health and Well-Being Services.

26 Apr 2011

Researchers report game-changing advance in stem cell science

In a paper published in the April 25 early online edition of the Proceedings of the National Academy of Sciences, researchers at the University of California, San Diego School of Medicine, the Gladstone Institutes in San Francisco and colleagues report a game-changing advance in stem cell science: the creation of long-term, self-renewing, primitive neural precursor cells from human embryonic stem cells that can be directed to become many types of neuron without increased risk of tumor formation.

26 Apr 2011

Bioengineering students develop new device that can detect patients with dry eye

Rice University bioengineering students responded to an ophthalmologist's cry for help with a device to diagnose dry eye, the itching and burning sensation that results when a person doesn't produce enough tears or the tears evaporate too quickly.

26 Apr 2011

STAA receives CE Mark approval for Visian Implantable Collamer Lens V4 design

STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive ophthalmic lenses for refractive surgery, today announced CE Mark approval for its Visian Implantable Collamer Lens V4c design.

25 Apr 2011

Promedior to present PRM-151 study data in age-related macular degeneration at ARVO meeting

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic, inflammatory and neovascular diseases, today announced that data from preclinical studies of PRM-151 will be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, being held May 1-5, 2011 in Ft. Lauderdale, FL.

22 Apr 2011

WSU researcher develops potential vaccine for Chlamydia

A Wayne State University School of Medicine researcher has developed a potential first ever vaccine for Chlamydia, the world's most prevalent sexually transmitted disease and the leading cause of new cases of blindness.

21 Apr 2011

Researchers create artificial cornea using pig and human stem cells

Researchers extracted pig corneal cells and replaced them with human stem cells. Thus, the University of Granada takes the lead in the making of bioartificial organs, a field so far led by the Hospital Gregorio Marañón in Madrid.

15 Apr 2011

Older women with high vitamin D status less likely to have early AMD

Women under the age of 75 with high vitamin D status were less likely to have early age-related macular degeneration, the leading cause of irreversible vision loss in adults, a University at Buffalo study has shown. The disease affects approximately 9 percent of Americans aged 40 and older.

12 Apr 2011

Long-term delivery of CNTF slows loss of visual acuity caused by geographic atrophy

A phase 2 clinical trial for the treatment of a severe form of age-related macular degeneration called geographic atrophy (GA) has become the first study to show the benefit of a therapy to slow the progression of vision loss for this disease. The results highlight the benefit of the use of a neurotrophic factor to treat GA and provide hope to nearly one million Americans suffering from GA.

8 Apr 2011

A2AAR-selective agonists may prevent permanent vision damage from traumatic optic nerve injury

Scientists want to protect the optic nerve when the eye takes a blow on the battlefield or in a car wreck.

7 Apr 2011

Gender gap in general surgery specialty shrinking

The gender gap among United States Medical Graduates (USMG) in the traditionally male-dominated specialty of general surgery is shrinking, according to study results published in the March issue of the Journal of the American College of Surgeons. These findings align with the overall trend of increasingly equal gender enrollment of medical students.

6 Apr 2011

Neurotech’s NT-501 intraocular implant slows progression of vision loss in GA subjects

Neurotech Pharmaceuticals, Inc., today announced that it was reported in the Proceedings of the National Academy of Sciences that its product candidate NT-501 slowed progression of vision loss in patients with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD) in a Phase 2 study.

6 Apr 2011

Merck enters definitive agreement to acquire Inspire

Merck, known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Merck will acquire Inspire, a specialty pharmaceutical company focused on developing and commercializing ophthalmic products.

6 Apr 2011

New Mexico Software annual revenue decreases 5% to $3.48 million

New Mexico Software, Inc. announced today its financial results, reporting annual revenue in 2010 decreased approximately 5% to $3.48 million compared to $3.66 million in 2009.

1 Apr 2011

Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported the outcome from its Phase 3 program evaluating OMS103HP in patients undergoing arthroscopic anterior cruciate ligament reconstruction surgery.

1 Apr 2011

Ophthalmology News and Research

Further Reading

LSI announces publication of Emerging Medtech Companies report

Gene therapy approach using CD59 shows promise against AMD: Study

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

Too much TV raises risk of narrow eye blood vessels and heart disease in kids

Humana declares quarterly cash dividend, anticipates first quarter diluted EPS of $1.86

Researchers report game-changing advance in stem cell science

Bioengineering students develop new device that can detect patients with dry eye

STAA receives CE Mark approval for Visian Implantable Collamer Lens V4 design

Promedior to present PRM-151 study data in age-related macular degeneration at ARVO meeting

WSU researcher develops potential vaccine for Chlamydia

Researchers create artificial cornea using pig and human stem cells

Older women with high vitamin D status less likely to have early AMD

Long-term delivery of CNTF slows loss of visual acuity caused by geographic atrophy

A2AAR-selective agonists may prevent permanent vision damage from traumatic optic nerve injury

Gender gap in general surgery specialty shrinking

Neurotech’s NT-501 intraocular implant slows progression of vision loss in GA subjects

Merck enters definitive agreement to acquire Inspire

New Mexico Software annual revenue decreases 5% to $3.48 million

Omeros announces outcome from OMS103HP Phase 3 study in patients undergoing ACL surgery

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News